Trials / Completed
CompletedNCT01271452
Safety and Efficacy of Two Types of Botulinum Toxin Type A For the Treatment of Glabellar Lines
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 224 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the safety and efficacy of two different types of botulinum toxin type A for the treatment of glabellar frown lines.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | botulinum toxin type A | 20 units (total dose) botulinum toxin type A injected into glabellar region on Day 0 |
| BIOLOGICAL | botulinum toxin type A | 30 units (total dose) botulinum toxin type A injected into glabellar region on Day 0 |
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2011-01-01
- Completion
- 2011-04-01
- First posted
- 2011-01-06
- Last updated
- 2019-01-29
- Results posted
- 2012-01-16
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01271452. Inclusion in this directory is not an endorsement.